Bridged bicyclic kallikrein inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9815853
SERIAL NO

15177641

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are kallikrein modulating compounds, pharmaceutical compositions comprising the same, and uses thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLOBAL BLOOD THERAPEUTICS INC171 OYSTER POINT BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Li, Zhe San Diego, US 423 4884
Setti, Lina Fremont, US 5 73
Sham, Hing Palo Alto, US 12 112
Xu, Qing Foster City, US 228 2805
Yee, Calvin Daly City, US 6 140
Yu, Chul San Ramon, US 21 189
Yu, Ming Foster City, US 188 1569
Zancanella, Manuel San Mateo, US 18 71

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 14, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 14, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00